Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Some fat just won’t go away no matter how well you eat or how hard you work out. You might do everything right. Get up, prepare your meals and hit the gym. And still have a stubborn pouch or a few tricky spots. When people get to this point they start thinking about liposuction. Liposuction […]

The post Liposuction Specialist at a Trusted Cosmetic Surgery Center for Safe Body Contouring appeared first on Medical News Bulletin.

Migraine remains one of the most prevalent and disabling neurological disorders, yet many patients continue cycling through multiple therapies before reaching specialty headache care.
For primary care providers and general neurologists, identifying the right time to refer a patient to a dedicated headache center is vital to improving long-term outcomes.
Healio spoke with Lauren Aymen, DO, a board-certified neurologist and medical director of the Headache and Facial Pain Center at the Michigan Institute for Neurological Disorders, about managing treatment-resistant migraine, procedural

On the heels of a rise in private equity-owned practices, which can create unique challenges for physicians, major medical organizations have called for greater transparency and oversight.
ACP recently released a position paper on the “growing involvement” of private equity and corporatization in health care. That involvement “raises important questions about its effect on cost, quality, access and the physician workforce,” according to the position paper, because “private equity investment in health care is associated with increased costs and, in some settings, adverse effects on care

Editor’s note: This is a developing news story. Please check back soon for updates.
The FDA granted 510(k) clearance for iPredict-DR, an AI-powered screening software designed to detect more than mild diabetic retinopathy in adults with diabetes, according to a press release from iHealthScreen.
The clearance was supported by data from a clinical validation trial that looked at “diagnostic performance, safety and usability.” The software uses AI to examine color retinal fundus images taken with an iCare DRSplus camera, which is designed to be operable by minimally skilled health care workers.

Editor’s note: This is a developing news story. Please check back soon for updates.
More than 2.5 million bottles of steroid eye drops aimed at relieving inflammation have been recalled, according to the FDA.
Lupin Pharmaceuticals is recalling 2,530,182 bottles of prednisolone acetate ophthalmic solution 1%, including 5 mL, 10 mL and 15 mL bottles. The affected lots have expiration dates ranging from July 31, 2026, to March 31, 2028.
The stated reason for the recall is “presence of foreign substance.” The recall, issued on June 4, is class II, meaning the products could cause

Thunderbolt, a computer-assisted thrombectomy device meant to address distal occlusions in patients with acute ischemic stroke, has received clearance from the FDA, according to a press release from Penumbra.
Thunderbolt is the first computer-assisted vacuum thrombectomy (CAVT) technology to offer modulated aspiration, which can help physicians more consistently and comprehensively remove blood clots, said Donald Frei, MD, a neurointerventional radiologist at Swedish Medical Center in Denver.
“When the catheter engages the clot, the system automatically modulates suction to apply stress to the

Dalbavancin has been utilized for long-term suppressive antibiotic therapy for complicated gram-positive infections in certain patients with limited treatment options.
Dalbavancin is a lipoglycopeptide, and like other glycopeptides it inhibits bacterial cell wall synthesis in gram-positive organisms by binding to the D-alanyl-D-alanine terminus of peptidoglycan precursors. Although dalbavancin’s only FDA labeled indication is acute bacterial skin and soft tissue infections, it is commonly used for off-label indications such as bacteremia, endocarditis and osteomyelitis.
A distinguishing

Melatonin reduced chronic musculoskeletal pain to a degree similar to pain medications like opioids, although most of the differences did not reach clinically meaningful thresholds, according to a systematic review published in PAIN.
“Melatonin is already in people’s homes, it’s inexpensive, and we know it’s safe,” Kangchao Wu, a PhD student from the Charles Perkins Centre in Australia, said in a press release. “What’s exciting is that melatonin may also help manage chronic pain, opening the door to reducing reliance on medications that come with more risks.”
The use of melatonin among

Middle-aged women have more problematic alcohol consumption patterns but lower awareness about the substance’s effects on breast cancer risk than women of other ages, according to survey results.
“It really is a perfect storm,” Dipali V. Rinker, PhD, LPC, research assistant professor in the Prescription Drug Misuse Education and Research (PREMIER) Center at University of Houston, told Healio. “These findings suggest this is a particularly high-risk group that could benefit from education and interventions to help them reduce alcohol use and simultaneously reduce their breast cancer risk.”
The

Johnson & Johnson announced that the FDA approved its dual energy catheter ablation platform designed to deliver radiofrequency and pulsed field ablation energy via a single catheter.
The platform (Dual Energy Thermocool Smarttouch SF Platform) is integrated with the company’s existing mapping, imaging and pulsed field index guidance system (CARTO), and is indicated for the treatment of refractory recurrent symptomatic paroxysmal or persistent atrial fibrillation, according to a company press release.
“Electrophysiologists need technologies that support different anatomies, substrates,